Hospital
Ohiohealth Corporation
Ohiohealth Corporation was paid $11.81M by Medicaid between Jan 2018 and Dec 2024, across 184 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.
33Billing provider infoOHIOHEALTH CORPORATION
DUBLIN, OH 43016
DUBLIN, OH 43016
33aNPI1801937008assigned 02/09/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.81M
24GClaims271,466
24DCodes billed184
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#67 of 101
Median peer was paid$22.32M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BROWNING, MICHAEL controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,010 | $848K | |
| 2019 | 15,385 | $634K | |
| 2020 | 12,018 | $686K | |
| 2021 | 18,264 | $914K | |
| 2022 | 19,268 | $877K | |
| 2023 | 113,355 | $4.87M | |
| 2024incomplete | 73,166 | $2.98M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 14,084 | 12,292 | $2.52M |
| 96361 | Intravenous infusion, hydration; each additional hour | 19% | 7,243 | 5,068 | $2.30M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 11,139 | 10,041 | $1.63M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.8% | 3,629 | 2,970 | $685K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.8% | 2,072 | 1,733 | $565K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 1,280 | 1,036 | $323K |
| G0378 | Hospital observation service, per hour | 2.5% | 3,334 | 1,284 | $293K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.3% | 1,279 | 1,157 | $275K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.1% | 1,140 | 939 | $247K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.0% | 859 | 721 | $239K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.9% | 860 | 695 | $229K |
| 59025 | Fetal non-stress test | 1.7% | 1,135 | 570 | $204K |
172 more codes
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.4% | 823 | $165K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.4% | 924 | $163K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 1,376 | $153K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 1,186 | $144K |
| 70496 | 1.1% | 382 | $134K | |
| 93976 | <1% | 824 | $112K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 531 | $89K |
| 80053 | Comprehensive metabolic panel | <1% | 8,435 | $86K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 603 | $71K |
| 76642 | <1% | 427 | $68K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 321 | $58K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,901 | $53K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,994 | $50K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 483 | $50K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,374 | $47K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,171 | $46K |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,682 | $43K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 707 | $40K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,612 | $35K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 623 | $35K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,390 | $31K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,270 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 22,054 | $22K |
| J3490 | Unclassified drugs | <1% | 2,275 | $22K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,358 | $22K |
| 93971 | <1% | 262 | $22K | |
| 82805 | <1% | 764 | $21K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 765 | $20K |
| 76830 | Ultrasound, transvaginal | <1% | 537 | $20K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 550 | $20K |
| 86900 | <1% | 863 | $19K | |
| 96376 | <1% | 1,707 | $18K | |
| 70498 | <1% | 368 | $18K | |
| 76536 | <1% | 127 | $17K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 63 | $17K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 989 | $15K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 67 | $14K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 164 | $12K |
| 81001 | <1% | 11,780 | $10K | |
| 84484 | <1% | 3,109 | $10K | |
| 80051 | <1% | 2,778 | $10K | |
| 76801 | <1% | 254 | $9K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,413 | $9K |
| 86850 | <1% | 840 | $9K | |
| 72100 | <1% | 235 | $8K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 720 | $8K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 257 | $8K |
| 71250 | <1% | 96 | $7K | |
| 70486 | <1% | 62 | $7K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 48 | $7K |
| 83605 | <1% | 2,175 | $7K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 22 | $7K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,802 | $6K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,314 | $6K |
| 82248 | <1% | 4,504 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,104 | $6K |
| 73560 | <1% | 455 | $6K | |
| 73030 | <1% | 238 | $5K | |
| 84703 | <1% | 5,442 | $5K | |
| 77062 | <1% | 98 | $5K | |
| 82077 | <1% | 1,014 | $5K | |
| 85610 | <1% | 1,830 | $5K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 34 | $5K |
| 83690 | <1% | 3,780 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,797 | $5K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,895 | $5K |
| 85027 | <1% | 1,779 | $5K | |
| 73630 | <1% | 299 | $5K | |
| 74018 | <1% | 122 | $4K | |
| 86901 | <1% | 863 | $4K | |
| 76770 | <1% | 26 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 152 | $4K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,463 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,518 | $3K |
| 96367 | <1% | 96 | $3K | |
| 88307 | <1% | 17 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,406 | $3K |
| 81025 | <1% | 522 | $3K | |
| 73130 | <1% | 142 | $3K | |
| 97116 | <1% | 113 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 784 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,294 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,410 | $2K |
| 83880 | <1% | 782 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,044 | $2K |
| 83735 | <1% | 1,129 | $2K | |
| 85730 | <1% | 871 | $2K | |
| 72131 | <1% | 18 | $2K | |
| 88304 | <1% | 88 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 274 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 79 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,765 | $2K |
| 82375 | <1% | 690 | $2K | |
| 85379 | <1% | 587 | $2K | |
| 73610 | <1% | 105 | $2K | |
| 97163 | <1% | 49 | $1K | |
| 80076 | <1% | 1,105 | $1K | |
| 82330 | <1% | 803 | $1K | |
| 77066 | Tomosynthesis, mammo | <1% | 125 | $1K |
| C1769 | Guide wire | <1% | 99 | $1K |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,045 | $1K |
| 76820 | <1% | 18 | $1K | |
| 87040 | <1% | 142 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 32 | $1K |
| J1815 | Injection, insulin, per 5 units | <1% | 353 | $1K |
| 87077 | <1% | 250 | $989.56 | |
| 83050 | <1% | 690 | $955.68 | |
| 82947 | <1% | 3,549 | $947.17 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,009 | $947.01 |
| 84702 | <1% | 590 | $928.27 | |
| 82565 | <1% | 2,861 | $856.51 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 193 | $826.67 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 208 | $818.36 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 231 | $800.98 |
| 84520 | <1% | 2,843 | $758.76 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 774 | $754.46 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 193 | $748.40 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 241 | $729.17 |
| J3535 | Drug administered through a metered dose inhaler | <1% | 88 | $719.85 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,018 | $685.76 |
| 87081 | <1% | 44 | $583.70 | |
| 80143 | <1% | 129 | $565.65 | |
| 80179 | <1% | 109 | $510.66 | |
| 76942 | <1% | 20 | $481.68 | |
| 86140 | <1% | 69 | $386.69 | |
| 97167 | <1% | 17 | $378.78 | |
| 85018 | <1% | 832 | $359.39 | |
| 85652 | <1% | 133 | $327.17 | |
| 87186 | <1% | 175 | $320.21 | |
| 73110 | <1% | 15 | $257.21 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 379 | $249.90 |
| 82570 | <1% | 107 | $248.64 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 88 | $247.94 |
| 80061 | Lipid panel | <1% | 54 | $247.01 |
| 84100 | <1% | 160 | $228.80 | |
| 84132 | <1% | 807 | $213.08 | |
| 84295 | <1% | 730 | $200.12 | |
| 82435 | <1% | 722 | $195.26 | |
| 85384 | <1% | 48 | $174.22 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 89 | $170.52 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 63 | $166.26 |
| 87210 | <1% | 60 | $163.08 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 77 | $150.34 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 178 | $134.04 |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 70 | $132.47 |
| 73502 | <1% | 31 | $126.33 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 321 | $118.88 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 169 | $118.51 |
| 83615 | <1% | 190 | $109.70 | |
| 82607 | <1% | 46 | $106.37 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 129 | $100.65 |
| 84550 | <1% | 178 | $99.50 | |
| 84156 | <1% | 76 | $90.44 | |
| 82746 | <1% | 42 | $80.40 | |
| 87420 | <1% | 13 | $76.27 | |
| 82040 | <1% | 14 | $69.31 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 59 | $67.68 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 49 | $56.46 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 150 | $44.07 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 55 | $42.14 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 411 | $35.56 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 18 | $33.67 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 20 | $28.11 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 58 | $23.15 |
| 85007 | <1% | 51 | $21.97 | |
| C9399 | Unclassified drugs or biologicals | 0% | 15 | $0.00 |
| 83550 | 0% | 16 | $0.00 | |
| J0173 | Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg | 0% | 16 | $0.00 |
| 36416 | 0% | 14 | $0.00 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 71 | $0.00 |
| 83540 | 0% | 16 | $0.00 | |
| 20985 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROWNING, MICHAEL (CFO, OHIOHEALTH)
Parent organizationOHIO HEALTH CORPORATION
| Provider | Location | Paid |
|---|---|---|
| Ohiohealth Corporation | Columbus, OH | $214.99M |
| Ohiohealth Corporation | Columbus, OH | $76.95M |
| Ohiohealth Corporation | Columbus, OH | $72.29M |
| Ohiohealth Corporation | Columbus, OH | $44.08M |
| Medcentral Health System | Mansfield, OH | $36.92M |
| Marion General Hospital, INC. | Marion, OH | $36.47M |
| Sheltering Arms Hospital Foundation, INC. | Athens, OH | $26.88M |
| Ohiohealth Berger Hospital LLC | Circleville, OH | $16.38M |
| Grady Memorial Hospital | Delaware, OH | $9.51M |
| Hardin Memorial Hospital | Kenton, OH | $7.27M |
| Medcentral Health System | Mansfield, OH | $3.13M |
| Madison Family Health Corporation | London, OH | $1.03M |
| Marion General Hospital, INC. | Marion, OH | $683K |
| Medcentral Health System | Mansfield, OH | $477K |
| Sheltering Arms Hospital Foundation | Athens, OH | $435K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.